Product NDC: | 54868-0173 |
Proprietary Name: | METHOTREXATE |
Non Proprietary Name: | methotrexate |
Active Ingredient(s): | 25 mg/mL & nbsp; methotrexate |
Administration Route(s): | INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 54868-0173 |
Labeler Name: | Physicians Total Care, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA089343 |
Marketing Category: | ANDA |
Start Marketing Date: | 20030326 |
Package NDC: | 54868-0173-0 |
Package Description: | 2 mL in 1 VIAL (54868-0173-0) |
NDC Code | 54868-0173-0 |
Proprietary Name | METHOTREXATE |
Package Description | 2 mL in 1 VIAL (54868-0173-0) |
Product NDC | 54868-0173 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | methotrexate |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS |
Start Marketing Date | 20030326 |
Marketing Category Name | ANDA |
Labeler Name | Physicians Total Care, Inc. |
Substance Name | METHOTREXATE |
Strength Number | 25 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] |